Treatment of acute salpingitis with sulbactam/ampicillin. Comparison with cefoxitin.
Sulbactam/ampicillin and cefoxitin were compared in the treatment of 20 patients with acute salpingitis diagnosed during laparoscopy. Results were evaluated during laparoscopic follow-up at 2 months. Sulbactam/ampicillin appeared to be a better treatment, producing better results in tubal patency, adhesions and persistent inflammation than cefoxitin. In addition, the combination of sulbactam/ampicillin with doxycycline appears to provide better results than the combination of cefoxitin with doxycycline in chlamydial salpingitis. It is concluded that sulbactam/ampicillin is an effective treatment for nonchlamydial salpingitis.
D000208:Acute Disease; D000328:Adult; D000667:Ampicillin / Q000008:administration & dosage / Q000627:therapeutic use*; D002440:Cefoxitin / Q000627:therapeutic use*; D002690:Chlamydia Infections / Q000188:drug therapy; D004318:Doxycycline / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005298:Fertility; D006801:Humans; D010397:Penicillanic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D011379:Prognosis; D012488:Salpingitis / Q000188:drug therapy*; D013407:Sulbactam; D000267:Tissue Adhesions
D002440:Cefoxitin; D000667:Ampicillin; D010397:Penicillanic Acid; D004318:Doxycycline; D013407:Sulbactam